Breast Cancer Adjuvant Radiotherapy in Up-Front to Chemotherapy: Is There a Worthwhile Benefit? A Preliminary Report.
Grazia LazzariIlaria BeneventoAntonietta MontagnaBarbara D'AndreaGiuseppina De MarcoGiovanni CastaldoAntonella BianculliRaffaele TucciarielloVito MetalloAngela Pia SolazzoPublished in: Breast cancer (Dove Medical Press) (2024)
As a new PORT approach in BC, AH-RT up-front to the third-generation A-CT appeared safe with a low acute toxicity profile, providing an advantage in shortening the time from surgery to PORT initiation and the overall adjuvant treatment time.
Keyphrases
- early stage
- locally advanced
- minimally invasive
- robot assisted
- liver failure
- coronary artery bypass
- laparoscopic surgery
- radiation therapy
- oxidative stress
- respiratory failure
- squamous cell carcinoma
- radiation induced
- rectal cancer
- contrast enhanced
- acute coronary syndrome
- hepatitis b virus
- surgical site infection
- coronary artery disease
- combination therapy
- percutaneous coronary intervention
- atrial fibrillation
- oxide nanoparticles